Gene · 8535
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Time-restricted eating alters the 24-hour profile of adipose tissue transcriptome in men with obesity. | Obesity (Silver Spring) | 2023 | 35912794 | PubTator, text mining | PubMed |
| Regulatory roles of NAT10 in airway epithelial cell function and metabolism in pathological conditions. | Cell Biol Toxicol | 2023 | 35877022 | PubTator, text mining | PubMed |
| Local Patterns in 2-Year T1ρ and T2 Changes of Hip Cartilage Are Related to Sex and Functional Data: A Prospective Evaluation on Hip Osteoarthritis Participants. | J Magn Reson Imaging | 2023 | 35852477 | PubTator, text mining | PubMed |
| COL1A1 and FGFR2 Single-Nucleotide Polymorphisms Found in Class II and Class III Skeletal Malocclusions in Javanese Population. | Eur J Dent | 2023 | 35672017 | PubTator, text mining | PubMed |
| An interpretation of the genetic polymorphism and population genetic background of Ankang Han population via a novel InDel panel. | Forensic Sci Res | 2022 | 36817236 | PubTator, text mining | PubMed |
| The Role of LINC01564, RAMS11, CBX4 and TOP2A in Hepatocellular Carcinoma. | Biomedicines | 2022 | 36672564 | PubTator, text mining | PubMed |
| Investigating Foot Morphology in Rock Climbing Mammals: Inspiration for Biomimetic Climbing Shoes. | Biomimetics (Basel) | 2022 | 36648794 | PubTator, text mining | PubMed |
| Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects. | Cancers (Basel) | 2022 | 36612246 | PubTator, text mining | PubMed |
| Chromobox Family Proteins as Putative Biomarkers for Breast Cancer Management: A Preliminary Study Based on Bioinformatics Analysis and qRT-PCR Validation. | Breast Cancer (Dove Med Press) | 2022 | 36605919 | PubTator, text mining | PubMed |
| A multiple criteria decision analysis based approach to remove uncertainty in SMP models. | Sci Rep | 2022 | 36572726 | PubTator, text mining | PubMed |
| Macroevolution in axial morphospace: innovations accompanying the transition to marine environments in elapid snakes. | R Soc Open Sci | 2022 | 36569233 | PubTator, text mining | PubMed |
| Identification of hepatocellular carcinoma subtypes based on PcG-related genes and biological relevance with cancer cells. | Clin Epigenetics | 2022 | 36566204 | PubTator, text mining | PubMed |
| Taking a closer look - how the microstructure of Dion-Jacobson perovskites governs their photophysics. | J Mater Chem C Mater | 2022 | 36561307 | PubTator, text mining | PubMed |
| RINGs, DUBs and Abnormal Brain Growth-Histone H2A Ubiquitination in Brain Development and Disease. | Epigenomes | 2022 | 36547251 | PubTator, text mining | PubMed |
| In Silico and Structure-Based Assessment of Similar Variants Discovered in Tandem Repeats of BRCT Domains of BRCA1 and BARD1 To Characterize the Folding Pattern. | ACS Omega | 2022 | 36530327 | PubTator, text mining | PubMed |
| Epigenetics of type 2 diabetes and diabetes-related outcomes in the Strong Heart Study. | Clin Epigenetics | 2022 | 36529747 | PubTator, text mining | PubMed |
| Ingenuity pathway analysis of α-synuclein predicts potential signaling pathways, network molecules, biological functions, and its role in neurological diseases. | Front Mol Neurosci | 2022 | 36523604 | PubTator, text mining | PubMed |
| Zinc finger myeloid Nervy DEAF-1 type (ZMYND) domain containing proteins exert molecular interactions to implicate in carcinogenesis. | Discov Oncol | 2022 | 36520265 | PubTator, text mining | PubMed |
| circPLIN2 promotes clear cell renal cell carcinoma progression by binding IGF2BP proteins and miR-199a-3p. | Cell Death Dis | 2022 | 36494341 | PubTator, text mining | PubMed |
| Glycoprotein attachment with host cell surface receptor ephrin B2 and B3 in mediating entry of nipah and hendra virus: a computational investigation. | J Chem Sci (Bangalore) | 2022 | 36465097 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8535/papers?page=17